Praxis Precision Medicines (PRAX) Misses Q1 EPS by 284c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($2.84). Revenue for the quarter came in at $430 thousand.

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
• RCM Technologies (RCMT) Tops Q2 EPS by 17c